# Kunlun Yiyun

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kunlun-yiyun

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.keyamedical.cn
- Latest round: Series A (Oct 23, 2019)
- Investors on record: 1

## About

Established in 2016 and based in Beijing, China, Kunlun Yiyun is a medical technology developer that provides AI healthcare solutions to patients, hospitals and biomedical research organisations. Kunlun Yiyun is a company with triple certified products from China NMPA, US FDA and EU CE. In October 2019, Kunlun Yiyun closed a series A funding from Yahui Mingzhe Asset Management.

Kunlun Yiyun's product line is divided into two categories, diagnostic and therapeutic, covering a wide range of areas such as vascular diseases, oncological diseases and intelligent diagnosis and treatment in imaging department. Specific products include DeepVessel FFR, DeepVessel AngioFFR, DeepVessel Cerebright, etc. Among them, its product DVFFR is a CTFFR product with triple certifications of NMPA in China, FDA in the U.S. and CE in the EU.

The company generates revenue by providing artificial intelligence medical diagnostic systems and treatment services.

## Funding rounds

- Series A, Oct 23, 2019 — Alwin Capital

## Investors

- Alwin Capital — Series A